Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Padcev
Pharma
BMS, overshadowed by ADC rival, wins FDA nod in 1L bladder cancer
Opdivo's market potential in this indication may be limited as its PD-1 rival, Merck & Co.'s Keytruda, has impressed in a high-profile combo.
Angus Liu
Mar 8, 2024 9:56am
Leqembi, Takeda, Roche—Fierce Pharma Asia
Feb 9, 2024 9:02am
Astellas raises expectations for Padcev, lowers them for Veozah
Feb 5, 2024 10:57am
JPM24: Pfizer oncology head still eyes ADC deals under new org
Jan 11, 2024 11:03am
Big Pharma deal spree, China plans and more—Fierce Pharma Asia
Jan 5, 2024 8:44am
FDA gives Keytruda-Padcev bladder cancer combo a curtain call
Dec 18, 2023 10:53am